Li G H
Tumor Hospital, Sun Yat-sen University of Medical Sciences, Guangzhou.
Zhonghua Zhong Liu Za Zhi. 1993 Mar;15(2):155-7.
From 1964 to 1991, 166 cases of huge primary liver carcinoma (larger than 10 cm in diameter) had been resected in our department. One hundred and forty-four cases were male and 22 cases were female. The tumor was located in the left lobe of the liver in 75 cases, in the right lobe in 75 cases and in both lobes in 16 cases. The tumors were 10 to 14.9 cm in diameter in 109 cases, 15 to 20 cm in 45 cases, larger than 20 cm 12 cases. The largest tumor was 28 x 26 cm in size. In this series, most of the tumors were hepatocellular carcinoma (93.4%). The livers in 125 cases (75.3%) were associated with cirrhosis. Ten cases of them underwent regular hepatectomy. 156 cases underwent irregular hepatectomy. During the operation interrupted matress sutures, hepatic clamp, occlusion of the circulation of the hepatoduodenal ligament and microwave coagulation were employed to reduce blood loss. In this series, 95 cases underwent radical resection and 75 cases palliative resection. The post-operative complications were jaundice and ascites in 18 cases, wounds infection in 7 cases and right pleural effusion in 7 cases. Three cases died within 1 month after hepatectomy with an operative mortality of 1.8%. In our study, 64 cases had been followed up over 5 years. The 5-year survival rate of the radical resection group were 17.5%. All of the 67 patients who underwent palliative resection died 2 to 36 months after hepatectomy with a median survival time of 7 months. The biological characteristics of huge primary liver carcinoma and the approach to improve the prognosis were discussed.
1964年至1991年,我科共切除166例巨大原发性肝癌(直径大于10cm)。其中男性144例,女性22例。肿瘤位于肝左叶75例,右叶75例,左右叶均有16例。肿瘤直径10至14.9cm者109例,15至20cm者45例,大于20cm者12例。最大肿瘤大小为28×26cm。在本组病例中,大多数肿瘤为肝细胞癌(93.4%)。125例(75.3%)肝脏伴有肝硬化。其中10例行规则性肝切除术,156例行不规则性肝切除术。术中采用间断褥式缝合、肝门阻断、肝十二指肠韧带血流阻断及微波凝固等方法减少出血。本组95例行根治性切除,75例行姑息性切除。术后并发症为黄疸、腹水18例,伤口感染7例,右侧胸腔积液7例。3例于肝切除术后1个月内死亡,手术死亡率为1.8%。本研究中,64例随访超过5年。根治性切除组5年生存率为17.5%。所有75例行姑息性切除的患者均于肝切除术后2至36个月死亡,中位生存时间为7个月。本文对巨大原发性肝癌的生物学特性及改善预后的方法进行了讨论。